Abstract:Background Acute Respiratory Distress Syndrome (ARDS) involves extensive pulmonary vascular endothelial injury. Mitochondrial damage plays a critical role in this endothelial injury. While mesenchymal stem cells (MSCs) are being explored as a cellular therapy for ARDS, their role in repairing mitochondrial damage in endothelial cells remains unclear. This study investigates the potential of MSCs to repair mitochondrial damage in ARDS lung endothelial cells through mitochondrial transfer and elucidates the underlying mechanisms. Methods This study established ARDS mouse models and cellular models of mitochondrial damage in pulmonary endothelial cells. Initially, we observed the ability and mechanisms of MSCs to transfer mitochondria to lung endothelial cells both in vivo and in vitro. Subsequently, we investigated how this mitochondrial transfer by MSCs affects the repair of mitochondrial and endothelial damage, as well as its impact on vascular regeneration in ARDS. Finally, we elucidated the mechanisms by which MSC-mediated mitochondrial transfer promotes vascular regeneration in ARDS. Various cell biology techniques, including flow cytometry, immunofluorescence staining, and confocal microscopy, were utilized for experimental observations. Results MSCs used tunneling nanotubes (TNTs) to transfer mitochondria to pulmonary endothelial cells. The endothelial cells internalized these mitochondria through dynamin-dependent clathrin-mediated endocytosis. The mitochondrial transfer increased mitochondrial complex I expression, reduced ROS production and apoptosis, and promoted cell proliferation in endothelial cells. The reparative effects of MSCs diminished when their mitochondrial transfer ability was inhibited. MSC-mediated mitochondrial transfer activated the tricarboxylic acid (TCA) cycle and citrate-dependent fatty acid synthesis in endothelial cells, leading to the release of pro-angiogenic factors and promoting vascular regeneration. Inhibiting TCA or fatty acid synthesis in endothelial cells significantly reduced MSC-promoted vascular regeneration. Conclusion MSCs transfer mitochondria to ARDS lung endothelial cells, activating the TCA cycle and fatty acid synthesis, which promotes endothelial cell proliferation and the release of pro-angiogenic factors, thereby enhancing vascular regeneration. These findings offer a promising therapeutic approach for repairing mitochondrial damage and promoting vascular regeneration in ARDS.

TFAM-Mediated mitochondrial transfer of MSCs improved the permeability barrier in sepsis-associated acute lung injury

Immunosuppressive Effect Of Mesenchymal Stem Cells On Lung And Gut Cd8(+) T Cells In Lipopolysaccharide-Induced Acute Lung Injury In Mice

Mesenchymal Stem Cells Alleviate LPS-induced Acute Lung Injury by Inhibiting the Proinflammatory Function of Ly6C+ CD8+ T Cells

MSC-Mediated Mitochondrial Transfer Promotes Metabolic Reprogramming in Endothelial Cells and Vascular Regeneration in ARDS

Comparative Effects of Umbilical Cord- and Menstrual Blood-Derived MSCs in Repairing Acute Lung Injury

Mitochondrial Transfer via Tunneling Nanotubes is an Important Mechanism by Which Mesenchymal Stem Cells Enhance Macrophage Phagocytosis in the In Vitro and In Vivo Models of ARDS

Mesenchymal stromal cell extracellular vesicles rescue mitochondrial dysfunction and improve barrier integrity in clinically relevant models of ARDS

Mesenchymal stem cells alleviate sepsis-induced acute lung injury by blocking neutrophil extracellular traps formation and inhibiting ferroptosis in rats

AdMSC-derived exosomes alleviate acute lung injury via transferring mitochondrial component to improve homeostasis of alveolar macrophages

Mesenchymal stem cell treatment restores liver macrophages homeostasis to alleviate mouse acute liver injury revealed by single-cell analysis.

A Therapeutic Role for Mesenchymal Stem Cells in Acute Lung Injury Independent of Hypoxia-Induced Mitogenic Factor

Mesenchymal stem cell exosomes reverse acute lung injury through Nrf-2/ARE and NF- κ B signaling pathways

The Vascular Endothelial Growth Factors-Expressing Character of Mesenchymal Stem Cells Plays A Positive Role in Treatment of Acute Lung Injury in Vivo

Therapeutic Effects of Bone Marrow-Derived Mesenchymal Stem Cells on Pulmonary Impact Injury Complicated with Endotoxemia in Rats

Mesenchymal stem cells inhibit ferroptosis by activating the Nrf2 antioxidation pathway in severe acute pancreatitis-associated acute lung injury

Human Umbilical Cord Mesenchymal Stromal Cell Small Extracellular Vesicle Transfer of Microrna-223-3p to Lung Epithelial Cells Attenuates Inflammation in Acute Lung Injury in Mice

Mesenchymal stem cell-derived exosome alleviates sepsis- associated acute liver injury by suppressing MALAT1 through microRNA-26a-5p: an innovative immunopharmacological intervention and therapeutic approach for sepsis

Human Mesenchymal Stem Cell Exosomes Attenuate Inflammation of Lung Epithelial Cells Through Mir-223 in Acute Lung Injury

Therapeutic Effects of Bone Marrow-Derived Mesenchymal Stem Cells in Models of Pulmonary and Extrapulmonary Acute Lung Injury.

Mesenchymal stem cell-derived microvesicles improve intestinal barrier function by restoring mitochondrial dynamic balance in sepsis rats

MSCs Modified with ACE2 Restore Endothelial Function Following LPS Challenge by Inhibiting the Activation of RAS